Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.03 USD
Change Today -0.0365 / -1.76%
Volume 1.6K
BASI On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 2:36 PM 04/28/15 All times are local (Market data is delayed by at least 15 minutes).

bioanalytical systems inc (BASI) Snapshot

Open
$2.06
Previous Close
$2.07
Day High
$2.06
Day Low
$2.00
52 Week High
04/28/14 - $2.87
52 Week Low
03/12/15 - $1.85
Market Cap
16.4M
Average Volume 10 Days
3.9K
EPS TTM
$-0.02
Shares Outstanding
8.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BIOANALYTICAL SYSTEMS INC (BASI)

Related News

No related news articles were found.

bioanalytical systems inc (BASI) Related Businessweek News

No Related Businessweek News Found

bioanalytical systems inc (BASI) Details

Bioanalytical Systems, Inc. provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in North America, the Pacific Rim, Europe, and internationally. It operates in two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing services. It also provides in vivo sampling services for the continuous monitoring of chemical changes in life; pharmacokinetic and safety testing services; product characterization, method development, and validation; bioanalytical testing to measure drug and metabolite concentrations in complex biological matrices; and stability testing to establish and confirm product purity, potency, and shelf life. The Research Products segment offers analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments; and Vetronics’ products, such as instruments and related software to monitor and diagnose cardiac function, and measure other vital physiological parameters in cats and dogs in veterinary clinics. Bioanalytical Systems, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.

150 Employees
Last Reported Date: 01/20/15
Founded in 1974

bioanalytical systems inc (BASI) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $387.9K
Chief Financial Officer and Vice President of...
Total Annual Compensation: $72.1K
Vice President of Bioanalytical Services
Total Annual Compensation: $61.1K
Compensation as of Fiscal Year 2014.

bioanalytical systems inc (BASI) Key Developments

Bioanalytical Systems, Inc. Promotes Philip A. Downing to Vice President of Preclinical Services

Bioanalytical Systems Inc. announced that Philip A. Downing has been promoted to Vice President, Preclinical Services. Philip has worked at BASi for 18 years, starting as an Analytical Chemist and earning responsibilities in more progressively influential leadership roles throughout his tenure.

Bioanalytical Systems Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended December 31, 2014

Bioanalytical Systems Inc. reported unaudited consolidated earnings results for the first quarter ended December 31, 2014. For the three months ended December 31, 2014, revenues decreased 6.0% to $5,845,000 compared to $6,220,000 in the first quarter of fiscal 2014. Gross profit decreased to $1,904,000, or 32.6% of revenue, in the first quarter of fiscal 2015 compared to $2,145,000, or 34.5% of revenue, during the comparable period last fiscal year. Operating income for the first quarter of fiscal 2015 amounted to $142,000 compared to operating income of $462,000 for the first quarter of fiscal 2014, primarily due to lower revenue and higher operating expenses. Net income was $182,000 for the first quarter of fiscal 2015, or $0.01 per diluted share, compared to a net loss of $662,000, or $0.09 per diluted share, for the first quarter of fiscal 2014. Excluding the change in fair value of the warrant liability in both periods, non-GAAP net income was $62,000 for the first quarter of fiscal 2015, or less than $0.01 per diluted share, compared to net income of $299,000, or $0.03 per diluted share, for the first quarter of fiscal 2014. EBITDA for the first quarter of fiscal 2015 amounted to $550,000 compared to EBITDA for the first quarter of fiscal 2014 of $912,000. Cash used in operating activities was $161,000 for the first quarter of fiscal 2015 due in part to higher working capital levels. Capital expenditures for plant, machinery and equipment of approximately $122,000 and higher working capital levels in the quarter. Income before income taxes was $183,000 against loss before income taxes of $662,000 last year.

Bioanalytical Systems Inc. to Report Q1, 2015 Results on Feb 12, 2015

Bioanalytical Systems Inc. announced that they will report Q1, 2015 results on Feb 12, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BASI:US $2.03 USD -0.0365

BASI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Charles River Laboratories International Inc $75.81 USD -1.06
Quintiles Transnational Holdings Inc $69.31 USD +0.41
View Industry Companies
 

Industry Analysis

BASI

Industry Average

Valuation BASI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.7x
Price/Book 1.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOANALYTICAL SYSTEMS INC, please visit www.basinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.